Solventum Corporation ( SOLV) - Key Metrics
SOLV Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $12.73 | $0.53 | $1.31 | $0.83 |
| 2026Q1 | $11.52 | $0.07 | -$1.08 | -$1.57 |
| 2025Q4 | $11.48 | $0.36 | $0.55 | $0.18 |
| 2025Q3 | $12.03 | $7.26 | $0.44 | -$0.12 |
| 2025Q2 | $12.41 | $0.52 | $0.97 | $0.34 |
SOLV Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 36.39 |
| 2026Q1 | 0% | 233.21 |
| 2025Q4 | 0% | 55.03 |
| 2025Q3 | 0% | 2.51 |
| 2025Q2 | 0% | 36.46 |
SOLV Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 1.08% | 0% |
| 2026Q1 | -2.40% | 0% |
| 2025Q4 | 0.23% | 0% |
| 2025Q3 | -0.17% | 0% |
| 2025Q2 | 0.45% | 0% |
SOLV
Price: $87.52
52 week price:
Earnings Per Share: 8.18 USD
P/E Ratio: 10.74
Exchange: NYQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United Kingdom
Market Capitalization: 15.0 billion